患有喘的孕妇的可治疗特征
Meera Ramlal1, Renske Van der Meer2, Sarah Bendien2
1Department of Biomedical Sciences, University of Amsterdam, Amsterdam, The Netherlands.
Respiration; international review of thoracic diseases
|March 12, 2024
概括
在患有喘的孕妇中管理可治疗的特征可以改善喘控制和怀孕结果. 本综述确定了怀孕期间个性化喘管理的关键特征.
科学领域:
- 生殖医学 生殖医学
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
背景情况:
- 喘影响8-10%的孕妇,如果不受控制,就会造成低出生体重和子宫前等风险.
- 目前的喘管理侧重于识别和治疗特定的"可治疗的特征".
研究的目的:
- 确定患有喘的孕妇可治疗的特征.
- 根据这些特征,概述个性化治疗策略.
- 为了改善喘控制和围产期的结果.
主要方法:
- 对最近关于怀孕期间喘管理的研究进行文献综述.
- 识别影响喘控制和怀孕的可治疗特征.
- 对已识别的特征进行个性化治疗选择的综合.
主要成果:
- 关键可治疗的特征包括分数呼出的氧化 (FeNO) 水平,药物坚持,肺功能,吸烟,肥胖,鼻炎,GERD,CRS,睡眠呼吸暂停和心理状况.
- 解决这些特征有可能改善喘控制和怀孕结果.
结论:
- 可治疗的特征方法对优化怀孕期间喘护理有希望.
- 进一步的研究对于验证管理策略和确认方法的可行性和好处至关重要.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
285
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
285
Asthma: Pathogenesis and Management
396
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K


